COMPARATIVE-STUDIES OF SULPIRIDE AND CLASSICAL NEUROLEPTICS ON INDUCTION OF CATALEPSY, LOCOMOTOR-ACTIVITY, AND BRAIN DOPAMINE METABOLISM IN MICE

被引:46
作者
FUJIWARA, H
机构
[1] Department of Pharmacology, School of Dentistry, Iwate Medical University, Morioka, 020, 1-3-27, Chuodori
关键词
SULPIRIDE; PIMOZIDE; HALOPERIDOL; CATALEPSY; LOCOMOTION; DOPAMINE METABOLISM; MOUSE;
D O I
10.1016/0091-3057(92)90102-L
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The effects of the peripheral administration of sulpiride on the induction of catalepsy, the vertical (VMA) and horizontal (HMA) locomotor activities, and on the dopamine metabolism in the limbic system, striatum, and nucleus accumbens were examined using mice up to 7.5 h after administration of drugs. These effects were compared to those of pimozide and haloperidol. Sulpiride (1.25-160 mg/kg, IP) clearly induced catalepsy similar to pimozide (0.0625-4 mg/kg, IP) and haloperidol (0.0375-0.3 mg/kg, IP). During the induction of catalepsy, the intensity was the strongest at 4.5 h after administration and the ED50 value showed 11.5 mg/kg at that time. However, a moderate dose of sulpiride at 10-20 mg/kg did not show the induction of a dose- and time-dependent catalepsy. During the locomotor activity, the VMA was significantly inhibited at 1.5 h and 6 h after administration of pimozide (0.25 mg/kg, IP) and haloperidol (0.075 mg/kg, IP) as compared to the control group, while the HMA was significantly inhibited at 1.5 h after administration of sulpiride (40 mg/kg, IP) and pimozide (0.25 mg/kg, IP). Subsequently, in the dopamine metabolism, sulpiride, pimozide, and haloperidol: 1) considerably accelerated the turnover in the dopamine metabolism in three distinct brain areas; 2) increased the levels of the DOPAC, HVA, and 3-MT even 6 h after administration, as well as at 1.5 h after administration; and 3) decreased the levels of dopamine in the nucleus accumbens at 1.5 h after administration. These results indicate that sulpiride displays a mode of action different from pimozide and haloperidol with regard to the induction of catalepsy, but not with regard to the locomotion and brain dopamine metabolism.
引用
收藏
页码:301 / 308
页数:8
相关论文
共 45 条
[1]   TARDIVE-DYSKINESIA INDUCED BY SULPIRIDE [J].
ACHIRON, A ;
ZOLDAN, Y ;
MELAMED, E .
CLINICAL NEUROPHARMACOLOGY, 1990, 13 (03) :248-252
[2]   ANTIPSYCHOTIC PROPERTIES OF NEW N-(4-SUBSTITUTED-1-PIPERAZINYLETHYL)-PHTHALIMIDES AND N-(4-SUBSTITUTED-1-PIPERIDINYLETHYL)-PHTHALIMIDES [J].
ALRASHOOD, KA ;
MUSTAFA, AA ;
ALHAIDER, AA ;
GINAWI, OT ;
MADANI, AAE ;
ELOBEID, HA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1988, 77 (10) :898-901
[3]  
Angst J., 1971, PHARMACOPSYCHIATRY, V4, P201
[4]   HYPOKINESIA IN MICE AND CATALEPSY IN RATS ELICITED BY MORPHINE ASSOCIATED WITH ANTIDOPAMINERGIC AGENTS, INCLUDING ATYPICAL NEUROLEPTICS [J].
BARGHON, R ;
PROTAIS, P ;
COLBOC, O ;
COSTENTIN, J .
NEUROSCIENCE LETTERS, 1981, 27 (01) :69-73
[5]   EFFECT OF SULPIRIDE ON MONO-AMINERGIC MECHANISMS IN PSYCHOTIC WOMEN [J].
BJERKENSTEDT, L ;
HARNRYD, C ;
SEDVAL, G .
PSYCHOPHARMACOLOGY, 1979, 64 (02) :135-139
[6]   BRL-20596, A NOVEL ANILIDE WITH CENTRAL DOPAMINE ANTAGONIST ACTIVITY [J].
CAMPBELL, W ;
CLARK, MSG ;
MITCHELL, PJ ;
NEEDHAM, PL ;
SEMPLE, JM .
PSYCHOPHARMACOLOGY, 1986, 89 (02) :208-215
[7]  
CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140
[8]  
CHRISTENSEN AV, 1984, POL J PHARMACOL PHAR, V36, P249
[9]   PHARMACOTHERAPY OF PARKINSONS-DISEASE [J].
COHEN, MM ;
SCHEIFE, RT .
AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1977, 34 (05) :531-538
[10]   DIFFERENTIATION OF DOPAMINE MECHANISMS MEDIATING STEREOTYPED BEHAVIOR AND HYPERACTIVITY IN NUCLEUS ACCUMBENS AND CAUDATE-PUTAMEN [J].
COSTALL, B ;
NAYLOR, RJ ;
CANNON, JG ;
LEE, T .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1977, 29 (06) :337-342